Literature DB >> 6994264

Expression of human genes for adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase after genetic transformation of mouse cells with purified human DNA.

S C Lester, S K LeVan, C Steglich, R DeMars.   

Abstract

Human DNA purified from HeLa cells and from three strains of skin fibroblasts was precipitated with calcium phosphate and added to mouse cells that were deficient in adenine phosphoribosyltransferase (APRT) and hypoxanthine phosphoribosyltransferase (HPRT). Selection for cells possessing either of the phosphoribosyltransferases was imposed by blocking de novo synthesis of purine nucleotides with azaserine in a medium supplemented with adenine and hypoxanthine. The frequency of colony formation after selection was 1.7 x 10(-7)-3.3 x 10(-6). Excepting some azaserine-resistant colonies that appeared only in the first experiment and infrequent revertants expressing moust APRT, all characterized clones expressed the human forms of APRT or HPRT according to the criteria of specific immunoprecipitation and electrophoretic mobility. The frequency of transfer of the human APRT gene was much greater than that of HPRT. Transfer efficiency was not significantly reduced when HeLa DNA was sheared to 6.5-13.5 kb size or when the donor DNA was isolated from a transferent that expressed human APRT.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994264     DOI: 10.1007/bf01538799

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  14 in total

1.  New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions.

Authors:  C Karreman
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

2.  Functional complementation by electroporation of human BACs into mammalian fibroblast cells.

Authors:  J A Hejna; P L Johnstone; S L Kohler; D A Bruun; C A Reifsteck; S B Olson; R E Moses
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

3.  Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells.

Authors:  M Koi; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Cell cycle-dependent regulation of thymidine kinase activity introduced into mouse LMTK- cells by DNA and chromatin-mediated gene transfer.

Authors:  C A Schlosser; C Steglich; J R deWet; I E Scheffler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase.

Authors:  D J Jolly; A C Esty; H U Bernard; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Transformation of the Hprt gene with DNA from spermatogenic cells. Implications for the evolution of X chromosome inactivation.

Authors:  L Venolia; D W Cooper; D A O'Brien; C F Millette; S M Gartler
Journal:  Chromosoma       Date:  1984       Impact factor: 4.316

7.  Transformation with DNA from 5-azacytidine-reactivated X chromosomes.

Authors:  L Venolia; S M Gartler; E R Wassman; P Yen; T Mohandas; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting.

Authors:  P Kavathas; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Authors:  R C Mulligan; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Neoplastic transformation of normal and carcinogen-induced preneoplastic Syrian hamster embryo cells by the v-src oncogene.

Authors:  T M Gilmer; L A Annab; M Oshimura; J C Barrett
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.